Browsing: Biosimilar
Beginning in 2023, five years after their European counterparts, patients in the United States prescribed the autoimmune disease treatment Humira…
Beginning in 2023, five years after their European counterparts, patients in the United States prescribed the autoimmune disease treatment Humira…